Last reviewed · How we verify
NCT03401931: AI Fib
Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers
trial in Fibrillation, Atrial. Withdrawn.
9 January 2018
Quick facts
| Lead sponsor | Hospital St. Joseph, Marseille, France |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 9 January 2018 |
| Primary completion | 9 January 2018 |
| Estimated completion | 9 January 2018 |
| Sites | 3 locations across France, Netherlands |
Conditions studied
- Fibrillation, Atrial — all drugs for Fibrillation, Atrial →
- To Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation Procedure — all drugs for To Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation Procedure →
Sponsor
Hospital St. Joseph, Marseille, France
Who can join
18 and older, any sex, with Fibrillation, Atrial or To Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation Procedure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
pilot clinical study, multicenter, prospective, open, nonrandomized
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03401931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fibrillation, Atrial
Currently open trials in the same condition.
- NCT06200311 — Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men · NA · recruiting
- NCT06618833 — Medical and Sociological Characterization of the Population of Patients Admitted for a First Ablation of Atrial Fibrilla · NA · recruiting
Other Hospital St. Joseph, Marseille, France trials
Trials by the same sponsor.
- NCT05779735 — Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate · NA · unknown
- NCT05662657 — Prevalence of Post Traumatic Stress Disorder Related to Diabetes Diagnosis or Severe Hypoglycaemia in Adult With Type 1 · completed
- NCT05068973 — Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients · NA · unknown
- NCT04945746 — Dispersion Stability · NA · active not recruiting
- NCT04672642 — Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03401931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital St. Joseph, Marseille, France
- Last refreshed: 28 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03401931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing